Acquiring Company
Petauri
Acquired Company
Formulary Insights
Description
Petauri, a leading purpose-built pharmaceutical services platform, has announced the acquisition of Formulary Insights, a trusted partner to pharmaceutical and life sciences clients for US market access insights and strategy. This strategic acquisition is intended to integrate Formulary Insights' agile market research and real-world market access expertise with Petauri Advisors, Petauri's consulting arm, to expand its offerings in market access research and strategy development.
Quick answer
Petauri is acquiring Formulary Insights, announced November 13, 2024. Petauri is based in Nashville, Tennessee, United States.
- How much did Petauri pay for Formulary Insights?
- The deal value was not disclosed.
- What does Petauri do?
- Petauri™ is a purpose-built pharmaceutical services organization.
- Where are Petauri and Formulary Insights based?
- Petauri is based in Nashville, Tennessee, United States. Formulary Insights is based in Indianapolis, Indiana, United States.
- Who are the decision-makers at Petauri?
- Fundz holds 2 contacts at Petauri. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation (November 15, 2024)
- Lupin strengthens its presence in the South African market through the acquisition of nine leading brands (October 4, 2024)
- OraSure Technologies completes acquisition of Sherlock Biosciences, Inc. to expand its innovation pipeline in molecular testing market (December 19, 2024)
- Lupin Limited strengthens diabetes portfolio with acquisition of three key trademarks from Boehringer Ingelheim International GmbH (December 15, 2024)
- Medtronic completes acquisition of Fortimedix to enhance its surgical technology portfolio (November 22, 2024)
- Flashpoint Therapeutics announces $50M Partnership with KAIMRC and Clinical Pipeline Expansion (November 14, 2024)
Who to call at Petauri, and when
When Petauri changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Petauri raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Petauri, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Petauri. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Petauri makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Formulary Insights?
Formulary Insights was acquired by Petauri, based in Nashville. The deal was reported on November 13, 2024. Petauri™ is a purpose-built pharmaceutical services organization. Petauri is privately held and operates in Biotechnology.
When did Petauri acquire Formulary Insights?
Petauri's acquisition of Formulary Insights was reported on November 13, 2024. Petauri, a leading purpose-built pharmaceutical services platform, has announced the acquisition of Formulary Insights, a trusted partner to pharmaceutical and life sciences clients for US market access insights and strategy. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Formulary Insights do?
Formulary insights, now Powered by Petauri, delivers more reliable and timely market access insights to the vast majority of major manufacturers. It is privately held, operating in Market Research, and is based in Indianapolis.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.